Distributor News

The new name represents a unified presence that will continue to fuel the company’s ongoing growth strategy and advance its impact across health care.

Walgreens Boots Alliance’s ownership of AmerisourceBergen’s common stock decreased from approximately 20% to 17%.

Prescription drugs make up the majority (98%) of distributors' sales, split among sales of brand-name drugs (55.3%), branded specialty (33.7%), generic drugs (7.8%), generic specialty (.6%) and biosimilar products (.7%).

TDS is adding the Outcomes digital ecosystem to its portfolio of pharmacy solutions.

Cardinal Health's Q1 revenue was $49.6 billion, an increase of 13% from the prior year period.

The new facility, in Jeffersonville, Ohio will distribute pharmaceutical, over-the-counter and home healthcare products.​​​​​​​

McKesson will be the buying group's primary vendor of pharmaceutical products effective Oct. 1, 2022.

McKesson will distribute pharmaceuticals to CVS Health's mail order, specialty pharmacies, retail pharmacies and distribution centers through June 2027.

The acquisition aligns with McKesson’s strategic growth focus by connecting biopharma and payer services to patients, the company said.

Debbie Weitzman, president of pharmaceutical distribution, will become the CEO of Cardinal Health's pharmaceutical segment, succeeding Victor Crawford who will step down.

​​​​​​​Cardinal Health’s revenue increased 11% to $47.1 billion in the fourth quarter and fiscal year 2022 revenues increased 12% to $181.4 billion.

Greene will report to CEO Mike Kaufmann and join the company's executive committee.